Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809146 · ClinicalTrials.gov registry record · Phase 3
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
A Phase 3 study of Status Epilepticus, sponsored by Robert Silbergleit.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,023
- Enrollment target
- 17
- Study locations
NCT00809146 is a Phase 3 study of Status Epilepticus that has completed, run by Robert Silbergleit. The registered enrollment target is 1,023 participants, below the 2,731-participant average among 10 other Status Epilepticus trials with a reported enrollment target (63% lower). The trial reports 17 study locations across 14 states.
The verdict
NCT00809146, a Phase 3 study of Status Epilepticus, has completed, sponsored by Robert Silbergleit.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,023 participants
- Enrollment target
- 17
- Study locations
Study Summary
The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
Conditions Studied
Interventions
- DRUG Intramuscular route of active treatment
- DRUG Intravenous route of active treatment
Study Locations (17)
California
- Stanford University - Palo Alto
- University of California-San Francisco - San Francisco
Michigan
- Henry Ford Health System - Detroit
- Wayne State University - Detroit
Pennsylvania
- University of Pennsylvania/York - Philadelphia
- Temple University-Main Line - Philadelphia
Arizona
- University of Arizona - Tucson
Georgia
- Emory University - Atlanta
Kentucky
- University of Kentucky - Lexington
Maryland
- University of Maryland - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,023 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00809146
The ClinicalTrials.gov registry entry for NCT00809146 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,023 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,731-participant average among 10 other Status Epilepticus trials with a reported enrollment target (63% lower). The listed sponsor is Robert Silbergleit, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Status Epilepticus appearing as the primary indexed condition, and to 2 interventions - of which Intramuscular route of active treatment is the first listed.
NCT00809146 reports 17 study locations spanning 14 distinct geographic areas - top geographies include California, Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00809146 about?
NCT00809146 is a clinical study titled "Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications". The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
What is the current status of trial NCT00809146?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,023 participants. The study started on 2009-06. Estimated completion is 2011-01.
What conditions does trial NCT00809146 study?
This clinical trial studies the following conditions: Status Epilepticus.
What interventions are being tested in trial NCT00809146?
The interventions under investigation include: Intramuscular route of active treatment (DRUG), Intravenous route of active treatment (DRUG).
Who is sponsoring clinical trial NCT00809146?
This trial is sponsored by Robert Silbergleit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00809146 being conducted?
This trial has 17 study locations across Arizona, California, Georgia, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Epilepticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
RECRUITING · Phase 3
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Improving Status Epilepticus Treatment Times
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Rapid-Response EEG in Children With Suspected Status Epilepticus
RECRUITING
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.